Royce Micro-Cap Trust, a closed-end fund investing in companies with market caps under $1 billion, reported a one-year NAV return of 39.07% as of September 30, 2026. The fund focuses on long-term capital growth through a diversified portfolio primarily in industrials, technology, and healthcare sectors. Despite recent market price fluctuations, the fund's average market cap is about $965 million, with a net asset value of $15.24 per share. Investors should consider the risks of small-cap investing and the fund's fees before investing.
Royce Micro-Cap Trust posted a one-year NAV return of 39.07% as of September 30, 2026, providing context on its recent performance. For readers following the Financials sector, here is Pluang's market snapshot as of Oct 28, 2026 21:21 WIB: out of 142 priced US Financials stocks, 66 rose and 73 fell. Notable movers include ITUB at USD 7.45 with a 1-day change of -2.87% and Pluang order activity of 5% Sell / 95% Buy, CRCL at USD 79.46 with -2.60% change and 99% Sell / 1% Buy activity, and PURR at USD 9.59 with -2.54% change and 0% Sell / 100% Buy activity, typical hold times ranging from 2 to 8 days.
On National First Responders Day, ADT celebrated local first responders and its monitoring professionals by unveiling a renovated monitoring center in Irving, Texas, part of a $2 million investment. The upgraded center features enhanced equipment and...
Cobalt Boats unveiled the 2027 265 Coastal Edition, a fully redesigned luxury outboard runabout tailored for coastal boating enthusiasts. Featuring wood-free construction, enhanced comfort, and advanced technology like dual 9-inch displays and option...
Presidio was named Enterprise Partner of the Year and Software and Services Partner of the Year for the Americas at the Cisco Partner Summit 2026. These awards recognize partners who excel in service and innovation, helping customers succeed through ...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
